Aytu BioScience Inc (AYTU) Financials

$2.30

$-0.05 (-2.13%)

As on 26-Aug-2026 16:00EDT

Market cap

$25 Mln

Revenue (TTM)

$57 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Operating Revenue	56.60	66.38	65.18	107.40	96.67	65.63
Cost of Revenue	21.22	20.55	16.13	40.77	46.39	36.43
Gross Profit	35.38	45.83	49.05	66.63	50.28	29.20
Operating Expenses	50.54	53.66	50.65	83.70	160.19	88.07
Operating Profit (EBIT)	-15.16	-7.83	-1.59	-17.07	-109.91	-58.87
Other Income	--	--	--	--	--	--
Profit before Tax	-33.67	-13.75	-10.38	-17.05	-108.89	-58.03
Provision for Tax	0.45	0.44	2.14	-0.06	-0.11	0.26
Profit after Tax (Net Income)	-34.06	-13.56	-15.84	-17.05	-108.78	-58.29
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-17.05	-110.17	-58.29

Liabilities ($ Mln)	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Shareholder's Funds	35.14	18.97	27.72	39.36	44.31	137.57
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	16.57	42.15	28.91	29.47	28.87	18.66
Current Liabilities	59.97	63.06	62.23	69.02	64.44	109.44
Total Liabilities	171.66	124.18	118.86	137.84	137.62	265.67

Assets ($ Mln)	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Non-Current Assets	44.36	45.00	56.97	65.01	77.69	160.43
Current Assets	67.33	79.18	61.89	72.83	59.93	105.23
Total Assets	171.66	124.18	118.86	137.84	137.62	265.67
Total Debt*	22.94	22.94	16.42	30.43	18.19	30.97
Net Current Assets	7.35	16.12	-0.34	3.82	-4.51	-4.20

Cashflow ($ Mln)	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Cash From Operating Activities	--	-1.94	-1.39	-5.13	-28.82	-25.96
Cash Flow from Investing Activities	--	-2.56	-0.33	-0.12	-3.25	-2.78
Cash from Financing Activities	--	15.44	-1.26	8.87	1.53	30.31
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Adjusted EPS ($)	-4.41	-2.00	-2.86	-3.09	-60.43	-49.57
Cash EPS ($)	--	-1.21	-1.37	-2.22	-54.74	-41.74
Adjusted Book Value ($)	--	2.79	5.00	7.13	24.62	116.98
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.29	-0.25	-0.93	-16.01	-22.08
Free Cash Flow per Share ($)	--	-0.76	-0.31	-0.93	-16.01	-22.08

Profitability Ratios	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
ROCE (%)	--	-31.53	-27.82	-25.78	-94.17	-42.24
ROE (%)	-116.80	-58.10	-47.24	-40.76	-119.62	-50.12
ROA (%)	-18.58	-11.16	-12.34	-12.38	-53.95	-27.86
EBIT Margin (%)	-55.53	-15.13	-8.16	-11.26	-39.42	-58.26
Net Margin (%)	-60.17	-20.43	-24.31	-15.88	-112.53	-88.81
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Revenue Growth (%)	-18.24	0.02	-0.39	0.11	0.47	1.38
EBIT Growth (%)	-4,307.23	-88.79	56.00	68.28	0.36	-113.38
Net Profit Growth (%)	-2,177.79	14.40	7.08	84.33	-86.62	-327.93
EPS Growth (%)	-4,687.56	0.30	0.07	0.95	-0.22	0.54
Book Value Growth (%)	-21.40	--	--	--	--	--

Valuation Ratios	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Price / Earnings	--	-1.09	-1.02	-0.52	-0.01	-0.10
Price / Book Value	0.71	0.78	0.58	0.22	0.03	0.04
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.14	-1.46	8.95	-4.97	0.00	0.44
Close Price ($)	2.73	2.18	2.92	1.60	13.80	100.20
High Price ($)	3.07	2.96	3.50	16.19	103.80	310.00
Low Price ($)	0.95	0.95	1.38	1.38	9.00	94.60
Market Cap ($ Cr)	25.44	--	--	--	--	--

Solvency Ratios	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Debt to Equity	0.27	1.21	0.59	0.77	0.41	0.23
Short term debt to equity ratio	0.35	0.58	0.18	0.22	0.09	0.19
Current Ratio	1.12	1.26	0.99	1.06	0.93	0.96
Quick Ratio	1.00	1.07	0.80	0.88	0.76	0.81
Interest Coverage	-14.02	-2.71	-1.11	-2.44	-0.26	-1.02

Operating Efficiency Ratios	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Debtors to sales (%)	43.27	46.93	36.09	26.94	22.46	42.93
Asset Turnover	0.31	0.55	0.51	0.78	0.48	0.31
Receivable days	--	150.43	146.99	86.13	94.25	92.80
Inventory Days	--	209.50	273.29	102.33	107.04	132.03
Payable days	--	185.86	269.39	109.60	119.06	155.79
Cash Conversion Cycle	--	174.07	150.88	78.86	82.22	69.04

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.